Skip to main content

Alpha Tau Medical Ltd.

DRTS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001871321

In the last 90 days, Alpha Tau Medical Ltd. insiders filed 0 open-market purchases and 4 sales; 74 institutions reported holding it in 13F filings for Q2 2026, worth $100.1M in total; ARK Invest is the only superinvestor holding it.

Other share classesDRTSW

Q2 2022 vs. Q1 2022

How the institutions holding Alpha Tau Medical Ltd. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of DRTS: Q1 2022 compared with Q2 2022
MeasureQ1 2022Q2 2022Change
Holders1214+2
Shares447.5K653.7K+206.2K (+46.1%)
Value$5.28M$5.92M+$639.0K (+12.1%)

New holders (7)

Institutions that held Alpha Tau Medical Ltd. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to DRTS in Q2 2022
InstitutionSharesValue% of portfolio
ETF Managers Group, LLC88,812$826.0K0.02%
JPMorgan Chase & Co77,387$697.0K0.00%
Phoenix Holdings Ltd.51,794$469.0K0.01%
Fred Alger Management, LLC20,554$185.0K0.00%
Geode Capital Management, LLC20,242$182.0K0.00%
HSBC Holdings PLC16,000$148.0K0.00%
Royal Bank of Canada1,293$12.0K0.00%

Sold out (5)

Institutions that held Alpha Tau Medical Ltd. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of DRTS in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Capstone Investment Advisors, LLC15,900$188.0K
Citadel Advisors LLC15,668$185.0K
Tower Research Capital LLC (TRC)3,020$36.0K
Clear Street LLC2,500$30.0K
Citigroup Inc460$5.00K